Tesamorelin Peptide Therapy
Tesamorelin Peptide Therapy is an innovative treatment utilizing a Growth Hormone-Releasing Hormone (GHRH) analog to naturally stimulate the body's pituitary gland. This therapy is designed to reduce visceral adipose tissue, particularly in individuals with conditions leading to central obesity or HIV-associated lipodystrophy. Patients undergo a thorough medical evaluation followed by a consistent self-administration protocol to achieve significant improvements in body composition and overall metabolic health.
Quick answer
Tesamorelin therapy reduces excess abdominal fat and improves body composition by naturally stimulating growth hormone production.
Options
Pick what fits
Benefits
What to expect
- Significant visceral fat reduction, especially in the abdominal area, while preserving lean muscle mass.
- Increased skeletal muscle area and density, particularly in truncal and abdominal muscle groups.
- Reduced cardiovascular disease risk and improved lipid profiles due to visceral fat loss.
Ideal for
Who this helps
How it works
The procedure
Conditions
Treats
FAQ
Frequently asked
More services
You might also like
Ready to book
Book your visit
Schedule your consultation with specialist Mohamed El Deeb.






